Passive antibody therapies: progress and continuing challenges.
about
Passive immunity in prevention and treatment of infectious diseasesWanted, dead or alive: New viral vaccinesMonoclonal antibody-based therapies for microbial diseasesTherapeutic antibodies: current state and future trends--is a paradigm change coming soon?Prevention and treatment of influenza with hyperimmune bovine colostrum antibodyDevelopment of genetically engineered human sperm immunocontraceptivesStatus of contraceptive vaccinesIsolation of human single chain variable fragment antibodies against specific sperm antigens for immunocontraceptive development.Preparation of recombinant viral glycoproteins for novel and therapeutic antibody discovery.Production of recombinant antibodies using bacteriophages.Vaccine for human contraception targeting sperm Izumo protein and YLP12 dodecamer peptide.Characterization and formulation of multiple epitope-specific neutralizing monoclonal antibodies for passive immunization against cryptosporidiosis.Characterization of an intestinal epithelial cell receptor recognized by the Cryptosporidium parvum sporozoite ligand CSLEfficacy of monoclonal antibodies against defined antigens for passive immunotherapy of chronic gastrointestinal cryptosporidiosis.Adjunctive immune therapy for fungal infections.Passive antibody administration (immediate immunity) as a specific defense against biological weapons.Contributions of humoral and cellular immunity to vaccine-induced protection in humans.Developments towards effective treatments for Nipah and Hendra virus infection.Development of human monoclonal antibodies against diseases caused by emerging and biodefense-related viruses.Active immunity induced by passive IgG post-exposure protection against ricin.Targeted localized use of therapeutic antibodies: a review of non-systemic, topical and oral applications.Overview on biotherapeutic proteins: impact on bioanalysis.Antibody Engineering for Pursuing a Healthier FutureBiological activity of a mouse-human chimeric immunoglobulin G2 antibody to Cryptococcus neoformans polysaccharide.Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis.Complexation Hydrogels as Oral Delivery Vehicles of Therapeutic Antibodies: An in Vitro and ex Vivo Evaluation of Antibody Stability and BioactivityExploitation of sperm-Escherichia coli interaction at the receptor-ligand level for the development of anti-receptor antibodies as the vaginal contraceptive.Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses
P2860
Q24550699-5DA273C8-5242-4B7D-A343-2436E90341EAQ27489979-A491725B-00AF-4EFC-BD68-858DD754BEC2Q27490830-9EC4F044-28A5-42D6-8ACC-B85D773BA224Q28728956-D3DC2C88-9292-4771-B68C-826EC3C00A74Q28748705-35E8BD31-B13B-469E-A6D2-F1B71A0FD2D6Q28749660-E45DD2AB-0FD7-4101-910C-E897875044B8Q28754430-8BC58B23-76D2-4587-946A-4464E4547E1CQ33326086-5B438CA6-5C5F-4C83-8B31-E2BC5C95B30BQ33413784-16826577-84E9-4308-8C9C-ECEB1CDDCA40Q33643027-B9686FC5-A6C2-4C6D-9AAC-4DA3E956B563Q33870581-3F68B2AE-B7B8-4986-8087-E75C5737F633Q34004213-AB75A4EF-36CB-4B09-8096-1E3E283F0B5CQ34006422-28D0C49B-5528-4093-B112-BACDEF0D2D45Q34105139-98D8A9EC-7305-40E7-B776-279C7B4DB691Q34350401-AF6158F1-359E-46F7-B89F-2722289A9FC2Q34762095-FDEFFF12-125E-419E-B77A-1903048769B7Q35615024-BD41A27A-4308-4EEC-BEDC-32A23B9901C0Q36379335-D11AC0BB-7009-4FD1-8D7C-998F4E5DC9AFQ36379337-4A169A77-D7C6-418B-82C5-2287EE59B4D2Q37576203-D9B7D2F8-6D84-4B86-BDF4-3B4C551CF752Q38323786-E2B7164E-4B63-4CB5-9C98-8EC4ADA8F1AEQ38663214-56782770-72C7-4229-BFE4-6B75D86CEC15Q38731632-00D8BEB0-77B8-4408-BEA1-340CA3988DE8Q39625324-28DC86C1-0B6A-47F6-B5F9-D005CDAC6AA5Q39741669-F5A52FB3-7C67-4A31-9B79-3DE705856D17Q40914685-4630A73A-2C37-4C58-9168-B6A7E6EEF27EQ51102500-D8D143B3-ECA3-4A9A-AFE5-529285981F7BQ56552815-129920DD-E7D9-45AC-95E3-1F37850329F4
P2860
Passive antibody therapies: progress and continuing challenges.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Passive antibody therapies: progress and continuing challenges.
@ast
Passive antibody therapies: progress and continuing challenges.
@en
type
label
Passive antibody therapies: progress and continuing challenges.
@ast
Passive antibody therapies: progress and continuing challenges.
@en
prefLabel
Passive antibody therapies: progress and continuing challenges.
@ast
Passive antibody therapies: progress and continuing challenges.
@en
P356
P1433
P1476
Passive antibody therapies: progress and continuing challenges.
@en
P2093
Casadevall A
P356
10.1006/CLIM.1999.4768
P577
1999-10-01T00:00:00Z